-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Monopar Therapeutics (MNPR) following Q4 results
-
-
-
-
-
-
-
Jones Trading Downgrades Monopar Therapeutics (MNPR) to Hold
-
-
-
-
-
-
-
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
-
-
-
-
-
-
-
Monopar Therapeutics Reports Third Quarter 2022 Financial Results and Recent Program Developments
-
-
-
-
-
-
-
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments
-
-
-
-
-
-
-
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Updates
-
-
-
-
-
-
-
Monopar Therapeutics Reports First Quarter 2020 Financial Results and Business Updates
-
1,223,240 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

